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Summary The failure of MCF7 cells to induce the formation of tumours after sub-cutaneous inoculation into
athymic nude mice can be obviated by the simultaneous injection of an extract of basement membrane
proteins (matrigel). Tumour growth is promoted and the latency period is low (2 to 4 weeks). In the absence of
matrigel, the simultaneous inoculation of fibroblasts and MCF7 cells also resulted in the development of
tumours, but with a longer latency period (about 2 months). The tumorigenic synergy between matrigel and
fibroblasts was evidenced by co-inoculating MCF7 cells MDA-MB 231 cells with fibroblasts and matrigel. This
co-inoculation decreased the delay of appearance of the tumours and/or accelerated the tumour growth,
depending upon the number of fibroblasts injected. Repeated injections of fibroblasts conditioned medium, at
the site of inoculum of tumour cells also enhanced tumour growth, suggesting the involvement of soluble
factors secreted by fibroblasts. Histologically, tumours induced by co-inoculation of tumour cells and fibrob-
lats contained more stromal structures including vimentin-positive cells, fibronectin and interstitial collagens.
These data suggest that human tumours may be reconstituted and grown in athymic nude mice using
basement membrane components and fibroblasts as inductors.
The appropriate nature of the microenvironment is one of
the factors involved in the ability to transplant human
tumours into athymic nude mice. Matrigel, an extract of
basement membrane proteins, allows the development of
tumours after transplantation of various cell types including
small cell lung carcinomas (Fridman et al., 1990), human
mammary cancer cells (Fridman et al., 1991), prostatic car-
cinoma PC3 cells and human primary prostatic carcinomas
(Pretlow et al., 1991). We have previously demonstrated the
rapid development of tumours in nude mice after injection of
human mammary carcinoma MCF7 cells in the presence of
matrigel and their responsiveness to oestrogen (Noel et al.,
1992c). In the absence of this basement membrane matrix,
MCF7 cells failed to induce the apparition of tumours.
Tumours are often infiltrated by cells arising from the host
such as macrophages, endothelial cells, lymphocytes and
fibroblasts. These cells represent an additional microenviron-
ment element able to modulate growth and other properties
of tumour cells. Co-injections of fibroblasts with human
epithelial tumoral cells from various tissues have been
reported to enhance tumour growth and their metastatic
capacity (Picard et al., 1986; Horgan et al., 1987; Camps et
al., 1990). These data suggest that several factors including
tumour cell-matrix interactions (Liotta, 1984), host cell-
tumour cell interactions (Picard et al., 1986; Horgan et al.,
1987; Camps et al., 1990; Miller et al., 1988; Price & Zhang,
1990) may affect tumour growth and the metastatic process.
We have investigated the influence of normal human fibro-
blasts on human breast cancer cells (MCF7 and MDA-MB-
231 cells) transplanted into nude mice in the presence or not
of matrigel. This report clearly demonstrates that fibroblasts
enhance the tumorigenicity of human breast cancer cells in
vivo. The promoting effects of fibroblasts and matrigel are
cumulative. The increased tumorigenicity observed by co-
inoculating fibroblasts and tumour cells could be at least
partly reproduced by medium conditioned by fibroblasts.
Materials and methods
Matrigel
Basement membrane proteins (matrigel) were prepared from
dialysed urea extract of EHS (Engelbreth-Holm-Swarm)
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tumour as previously described (Kleinman et al., 1986;
Emonard et al., 1987; Noel et al., 1991). Solid gels were
obtained by polymerising 1 ml of this preparation
(10mgml-') in 35 mm culture dishes, overnight at 37°C in a
humid atmosphere.
Cells
Normal human skin fibroblasts were obtained by outgrowth
from explants and used between passages 4 and 12. The
human breast carcinoma cell lines, MCF7 cells (Soule et al.,
1973) and MDA-MB-231 cells (Cailleau et al., 1974) were
kindly provided by Dr Leclercq (Bordet Institute, Brussels,
Belgium) and Dr R. Gol (University of Liege, Belgium),
respectively. Cells were grown in Dulbecco's Modified Eagles
Medium (DMEM) supplemented with 10% foetal calf serum
(Gibco), glutamine (292 mgml-'), sodium bicarbonate
(2,1 gl-1'), ascorbic acid (50 tgml-') and penicillin-
streptomycin (100 U ml-').
Preparation ofconditionedmedium (CM)
After three washings to eliminate serum, 8 ml of serum-free
medium was added to confluent monolayer of fibroblasts in
1Ocm Falcon plastic dishes. The medium was collected after
24 h, centrifuged to eliminate cell debris and used
immediately.
In vivo studies
Tumoral cells and/or fibroblasts were detached by trypsinisa-
tion, harvested by centrifugation, resuspended in serum-free
medium and mixed with 0.25 ml of matrigel (10 mgml-') in
a total volume of 0.5 ml. Cells were injected subcutaneously
(SC) into 6 to 8 week-old female athymic (nu/nu) mice (Iffa
Credo). The estradiol-dependent MCF7 cells were inoculated
into mice previously implanted SC with Silastic capsules
(Dow Corning) containing estradiol as previously described
(Robinson & Jordan, 1989; Noel et al., 1992c). In some
assays, MCF7 cells were mixed with matrigel and 0.1 ml of
conditioned medium (CM) of fibroblasts. CM (0.1 ml) was
reinjected weekly at the site of the primary inoculum and
inside the tumours after their appearance.
Injected mice were examined weekly and tumour volume
was calculated as previously described (Attia & Weiss, 1966;
Noel et al., 1992c). The latencyperiod was defined as the time
between injection and appearance of a 250 mm3 nodule which
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will maintain a progressive growth. Results are expressed as
the mean of the tumour volumes. Tumours presenting a
volume lower than 250 mm3 (determining the latency period)
were not taken into account because of technical imprecisions
of the measurements (Noel et al., 1992c).
Each experiment was repeated at least three times (control-
+ experimental variations), at three months intervals, by
using different batches of cultured MCF7 cells, fibroblasts
and distinct groups of nude mice (Iffa Credo). Each set of
animals, in each condition contained at least five to ten
individuals. Absolute values of tumour sizes in identical
groups could vary as much as 30% between each experiment,
probably due to uncontrolled variations (food intake, light-
ing, seasonal variations, environmental stress, temperature of
the unit, . . .). In any case, the absolute trends of variations
between the groups in each assay remained consistant and
inter-groups variations were of the same extent. The results
presented are representative experiment with absolute values
(n = 5-10). Inter-individual variations of tumour size inside
each group (n = 5-10) were always lower than 10%.
No death occurred-during the course of the experiments.
The tumours sizes were always maintained below 1,500 mm3
since such large tumours usually displayed extensive area of
central necrosis, ulcerations and subsequent infections and
death (data not shown). We therefore decided to finish the
assays when appropriate or when the tumours reached
1,250 mm3.
Histological examinations and immunohistochemistry
The tumours were excised, fixed in 10% buffered formalin,
embedded in paraffin, sectioned at 4jim intervals and stained
with hematoxylin and eosin. The immunohistochemistry was
performed as previously described (Noel et al., 1992c). For
the characterisation of the extracellular matrix, sections were
pretreated with pepsin (1 mgml-I in 0.01 N HCI, 10 min at
37C). Antiserums directed against vimentin (Calbiochem),
fibronectin and types I and III collagen were raised in rabbit
(Noel et al., 1992b). The anti-Thy antibody, kindly provided
by J. Boniver (University of Liege, Belgium) was specific for
the murine fibroblasts (Esterre et al., 1992). This species
specificity was verified in culture of human and murine
fibroblasts.
For transmission electron microscopy, small pieces of
tumour tissue (1 mm3) were fixed in 2.5% glutaraldehyde and
postfixed in 0.1 M osmium tetraoxide. After dehydration into
a graded series of ethanol, samples were embedded in Epon.
Ultrathin sections were contrasted with uranyl-acetate and
lead-citrate before examination with a JEOL 100 CX II
electron microscope (60 kV).
Quantification ofcollagen in tumours
Tumours were excised, frozen in liquid nitrogen and
lyophilised. Their dry weight was then determined. The
amount of hydroxyproline was measured by the method of
Bergman & Loxley (1963), after hydrolysis in 6 N HCI.
Statistical analysis
Differences between the experimental conditions were
evaluated using Student's t-test (P values lower than 0.02
were considered as significant).
MCF7 cells (3 x 106) were inoculated. However, co-injection
of 1 x 106 fibroblasts with 0.35 or 1.5 x 106 MCF7 cells
resulted in tumour development after approximately 2
months. This promoter effect of human fibroblasts was
similar for the two numbers of MCF7 cells inoculated
(Figure la and b; Table I).
Addition of matrigel induced a more rapid tumour take,
even when MCF7 cells were injected, without fibroblasts.
Tumours appeared during the first month of observation.
The latency period was 22 and 35 days after injection of
1.5 x 106 and 0.35 x 106 MCF7 cells, respectively (Table I).
Co-injection of fibroblasts with a low number of MCF7 cells
(0.35 x 106 cells) in the presence of matrigel shortened the
latency period (20 vs 35 days) (Table I; Figure la). The
latency period observed for 1.5 x 106 injected MCF7 cells,
was not modified when fibroblasts were added (Table I,
Figure lb). However, independently of the number of MCF7
cells injected simultaneously with fibroblasts, the incidence of
tumour always reached 100% and the volume of the tumours
was increased (Table I; Figure la and b). After 70 days of
observation, the volume reached 1,250 mm3 in the presence
of fibroblasts and only 750 mm3 in the absence of fibroblasts
(P<0.01).
The effect of fibroblasts on the tumorigenicity of an
estradiol-independent mammary cancer cell line (MDA-MB-
231) was also investigated in the presence of matrigel.
Inoculation of 1 x 106 fibroblasts simultaneously with
0.35 x 106 MDA cells shortened again the latency period and
increased the tumour growth (Figure 2) (P<0.02). The injec-
tion of fibroblasts alone used as control in the presence or
the absence ofmatrigel did never induced the development of
tumour.
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Results
Effect offibroblasts on human mammary cancer cells
tumorigenicity
Athymic nude mice were inoculated subcutaneously (SC)
with estradiol-dependent MCF7 cells in various experimental
conditions. In the absence of matrigel, we did not succeed in
producing tumours in the 15 nude mice injected with MCF7
cells alone (Noel et al., 1992a), even when high number of
Figure 1 Effect of co-inoculation of fibroblasts and MCF7 cells
upon tumour growth. Tumoral MCF7 cells were injected sub-
cutaneously into nude mice, alone (A), with 1 x 106 fibroblasts
(A), in the presence of matrigel (0), or in the presence of
matrigel and 1 x 106 fibroblasts (0). The tumour volume was
periodically estimated as described in Material and methods.
Interindividual variations of tumour sizes inside each group
(n = 5) were always lower than 10%. The experiment has been
repeated three times. a, injection of 0.35 x 101 MCF7 cells with
or without I x 101 fibroblasts. b, injection of 1.5 x 106 MCF7
cells with or without 1 x 106 fibroblasts.
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Table I Tumorigenicity of MCF7 cells after subcutaneous injection into athymic
nude mice in the presence or absence of fibroblasts
Tumorigenicity Latency period
(n/n)a (days)'
Without With 1 x 106 Without With I x 106
fibroblasts fibroblasts fibroblasts fibroblasts
Number of MCF7 cells:
in the absence of matrigel
0.35 x 106 0/5 3/5 70±3
1.5 x 106 0/5 3/5 65±2
Number of MCF7 cells:
in the presence of matrigel
0.35 x 106 10/15 15/15 35 ± 5 20 ± 2
1.5 x 106 8/10 10/10 22 ± 2 20 ± 2
aNumber of mice bearing tumour larger than 250 mm3/total number of injected
mice. bLatency period: time between injection and appearance of 250 mm3 nodule.
Dose-dependence offibroblasts effects
When a constant number of MCF7 cells (0.3 x 106) was
injected with different numbers of fibroblasts (from 0.3 x 106
to 0.9 x 106), in the presence of matrigel, the effect on
tumour take and on tumour growth (Figure 3) was related to
the number of fibroblasts. The effect was maximal at a
tumoral cells to fibroblasts ratio of 1 to 2 or 3 (P<0.01).
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Effect offibroblasts conditionedmedium (CM) on MCF7 cells
tumorigenicity
In an attempt to determine if the promoting effect of fibro-
blasts results from the production of soluble factors, MCF7
cells suspended in conditioned medium (CM) of fibroblasts
were injected with matrigel. This treatment was followed by a
weekly injection of CM at the primary site of inoculum. The
latency period was not modified as compared to injection of
tumoral cells alone (Figure 3). However, after repeated injec-
tions of CM, the growth rate and tumour size were increased
(P<0.01). After 70 days of observation, the volume reached
in these conditions was similar to that obtained after co-
inoculation of both cell types at a 1 to 3 MCF7 cells to
fibroblasts ratio (Figure 3).
Light and electron microscopy oftumours
The histology of tumours developed after injection of MCF7
cells in the presence of matrigel were studied by light and
electron microscopy. Tumours appeared to be well circum-
scribed. Cells were organised into nodules of malignant cells
l 78 100 with very few stromal cells (Figure 4a). Numerous mitotic
figures were regularly observed. Despite an extensive vas-
cularisation, central necrosis developed. In other areas of the and MDA-MB- tumour, cells lined up between stromal elements (Figure 4b).
f athymic nude The tumours developed after the simultaneous injection of
in the presence fibroblasts and MCF7 cells in the presence of matrigel were
as described in characterised by the regular presence of more abundant
of tumour sizes stromal structures (Figure 4c).
han 10%. The By electron microscopy, tumour cells presented features of
malignant MCF7 cells (high nuclear cytoplasmic ratio,
filaments arranged in bundles, numerous mitochondria)
(Figure 5a,b). Infiltration of fibroblasts characterised by their
abundant rough endoplasmic reticulum was observed in
tumours induced by injection of MCF7 cells alone (Figure
5a,b) or in the presence of fibroblasts (Figure 5c,d). In some
areas, cells were separated by a granular material resembling
--- - matrigel (Kleinman et al., 1986; Noel et al., 1991). Fibrillar
striated materials was found at the vicinity of fibroblasts
(Figure Sd). Cells were connected to desmosomes-like junc-
tions, interdigitating cytoplasmic projections or the mem-
brane of neighbouring cells were in juxtaposition (Figure 5d).
Vascularisation was evidenced in tumours obtained in both 60 7 conditions (Figure Se).
Figure 3 Effect of MCF7 cells to fibroblasts ratio or conditioned
medium (CM) of fibroblasts upon tumour growth in the presence
of matrigel. A constant number of MCF7 cells (0.3 x 106) and
matrigel were injected without (A) or with different numbers of
fibroblasts (interrupted lines: 0 = 0.3 x 106; A = 0.6 x 106;
O = 0.9 x 106). In one group of mice, MCF7 cells and matrigel
were injected in the presence of CM of fibroblasts ( + ). The
injection of CM or fibroblasts was repeated weekly, at the site of
the inoculum. The volume of tumour was measured as described
in Material and methods. Interindividual variations of tumour
sizes inside each group (n = 5) were always lower than 10%. The
experiment has been repeated three times.
Characterisation ofstromal structures
Since tumours induced by co-inoculation of fibroblasts and
tumour cells displayed more stromal structures, the extracel-
lular matrix deposition and stromal cells were characterised
by immunohistochemistry. Interstitial collagen types I and III
and fibronectin were evidenced in these structures surround-
ing epithelial tumour cells (Figure 6a). The content ofcollagen
was measured as hydroxyproline present in tumour lysates.
The tumours were excised 25 and 40 days after inoculation of
MCF7 cells in the presence or absence of fibroblasts. The912 A. NOEL et al.
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Figure 4 Histology of tumours obtained 1 month after injection of MCF7 cells into athymic nude mice, in the presence of
matrigel. MCF7 cells were injected alone a,b, in the presence of fibroblasts c, or with CM of fibroblasts d, as described in Materials
and methods (bar = 100pm).
collagen content of tumours developed after co-inoculation of
both cell types was double that of tumours induced by injec-
tion of MCF7 cells alone (92 ± 20fig collagen mg-' dry
weight vs 50 ± 10yg collagen mg-' dry weight; P<0.005).
Fibroblasts stained positively for vimentin. Surprisingly, the
fibroblasts as shown by using anti-Thy 1 antibodies revealed to
be exclusively of murine origin (Figure 6b). This antibody is
specific for murine fibroblasts and not for human fibroblasts,
as verified on our fibroblasts in culture (data not shown). All
stromal cells stained positively with this antibody.
Similar histological features were observed after repeated
injections of CM of fibroblasts, at the site of inoculation of
MCF7 cells with matrigel (Figure 4d).
Discussion
In this study, we demonstrate that the addition of fibroblasts
to MCF7 cells which are not tumorigenic by themselves
allows the take and growth of tumours. These data confirm
the helper effect of normal fibroblasts as observed for
different types of tumour cells of animal and human origin
derived from breast (Horgan et al., 1987; Camps et al., 1990),
rhabdomyosarcoma (Picard et al., 1986), melanoma (Tanaka
et al., 1988), prostate and bladder (Camps et al., 1990).
However, tumours induced by co-injection of MCF7 cells
and fibroblasts appeared only after 2 months, in a rather
small proportion of injected animals and grew slowly (Table
I and Figure 1). More recently, matrigel has been shown to
accelerate tumour growth in athymic nude mice (Fridman et
al., 1990; 1991; Pretlow et al., 1991). We observed similar
results since tumours developed 2 to 4 weeks after injection
of MCF7 cells in the presence of matrigel (Noel et al.,
1992c). The exact mechanisms operating in the enhancement
of tumorigenicity by matrigel are not clear and have been
previously discussed (Fridman et al., 1990; 1991; Noel et al.,
1992c). The effect of matrigel on the human cells
tumorigenicity was partially abolished by the addition of aTUMORIGENICITY WITH MATRIGEL AND FIBROBLASTS 913
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Figure 5 Electron micrographs of tumours obtained after injections of MCF7 cells in the presence of matrigel into athymic nude
mice. a,b, Tumour obtained after injection of MCF7 cells (M) alone. Rare presence of fibroblasts (F) was observed (bar = 1 jim).
c-d, Tumour obtained after injection of MCF7 cells (M) and fibroblasts. Fibroblasts (F) were surrounded by striated fibrillar
material (c), (bar = 1 jim). Cells were connected by desmosome (arrow) or interdigitating cytoplasmic projections (d)
(bar = 0.5jim). e, Capillary surrounded by extracellular matrix and tumoral MCF7 cells. (bar = 100jam).
synthetic peptide from the BI chain of laminin (Fridman et
al., 1990) suggesting that it could be at least partly ascribed
to specific cell-matrix interactions promoted by laminin (Noel
et al., 1988, 1993).
When fibroblasts were inoculated simultaneously with a
low number of MCF7 cells in the presence of matrigel, the
latency period was reduced and the tumour growth was
increased. These effects are correlated with the ratio of
tumoral cells to fibroblasts. In these conditions, all mice
developed tumours. Similar results were obtained with an
other breast cancer cell line (MDA-MB-231) and are not
restricted to the MCF7 cell line. The factors supplied by
fibroblasts and matrigel are cumulative as shown by the
results obtained with a low number of tumoral cells. Further-
more, injections of higher amounts of matrigel or repeated
injections of matrigel were unable to mimic the effect of
fibroblasts (data not shown). These results suggest that
fibroblasts and matrigel enhance tumour growth by distinct
mechanisms. Identical tumour sizes were obtained when
0.3 x 106 or 3 x 106 MCF7 cells were inoculated indicating
that the tumour growth was not proportional to the number
of MCF7 cells injected. The identical latency periods
observed when 1.5 x 106 MCF7 cells were injected in the
presence of matrigel, with or without fibroblasts suggest that
the latency period is minimal or that local host factors limit
the rate of tumour take.
Histological observations demonstrated the presence of
fibroblasts and stromal-like structures inside of the tumour
islets. This stroma contained fibronectin, collagen types I and
III as evidenced by immunohistochemistry. The content of
total collagen was twice as high in tumours induced by
co-inoculation of tumour cells and fibroblasts. This could be
ascribed at least partly to a modulation of collagen produc-
tion by fibroblasts in response to MCF7 cells. We have
indeed demonstrated the capacity of these mammary tumour
cells to secrete soluble factors which enhance collagen syn-
thesis by fibroblasts in vitro (Noel et al., 1992a,b).
The murine origin of fibroblasts surrounding epithelial914 A. NO1-L et al.
Figure 6 Immunoperoxidase stainings of tumours obtained after
injections of MCF7 cells and fibroblasts, in the presence of
matrigel into athymic nude mice. a, Immunostaining with a
polyclonal antibody localises the collagen type I in the stroma
surrounding tumour cells. b, Immunostaining of fibroblasts with
anti-Thy 1 antibody raised against human fibroblasts antigen.
(bar = I fLm)
tumour nests was determined using an antibody staining
specifically murine fibroblasts. Furthermore, the identical
histological features of tumours induced by addition of fibro-
blasts or by injections of medium conditioned by fibroblasts
indicate recruitment of murine fibroblasts rather than a per-
sistance of the injected human fibroblasts. In this regard,
fibroblasts have been shown to secrete several factors affect-
ing cell motility (for review, Stocker & Gherardi, 1991).
Various mechanisms may be involved in the fibroblasts-
mediated increase of tumorigenicity. Camps et al. (1990)
reported that lethally irradiated fibroblasts retain at least part
of their potential to accelerate tumour growth, suggesting the
involvement of the bio matrix surrounding the cells. This
effect could be ascribed to specific properties of its com-
ponents or to its capacity to bind growth factors (Nathan &
Sporn, 1991). For example, several forms of fibroblasts
growth factors (FGF) are deposited in the extracellular mat-
rix and function when bound to proteoglycans of the extra-
cellular matrix (Nathan & Sporn, 1991; Bashkin et al., 1989).
According to previous observations (Picard et al., 1986) and
to our results, fibroblasts conditioned medium (CM) mixed
with tumour cells also stimulates tumour growth (Figure 3).
The failure of CM to shorten the latency period could be
ascribed to subcutaneous dilution of soluble factors before
tumour take (Gartner et al., 1992). Nevertheless, these data
suggest the role of soluble growth factors secreted by fibrob-
lasts. The production of IGF-I and IGF-II (Clemmons, 1984;
Yee et al., 1988) by skin fibroblasts might be responsible for
this paracrine effect (Van Roozendaal et al., 1992). Further-
more, the matrigel, known to bind several cytokines via the
heparan sulfate proteoglycan (Noel et al., 1992a; Taub et al.,
1990; Vukicevic et al., 1992) could act as a 'reservoir'
accumulating these intercellular messengers.
The maximal stimulation is obtained when the tumour
cells are in contact with fibroblasts. It is likely that maximal
stimulation of tumorigenicity requires the continuous produc-
tion of factors by fibroblasts and cell-cell contacts. The
importance of contacts between tumour cells and fibroblasts
have been suggested by several studies (Gartner et al., 1992;
Tanaka et al., 1988; Coucke et al., 1992). The lung colonising
potential of a low metastatic clone of melanoma cells was
indeed increased when cells were cocultured in vitro with
fibroblasts. The CM of cocultured melanoma cells and
fibroblasts presented similar potential whereas medium from
monoculture of fibroblasts showed only a low activity
(Tanaka et al., 1988). We have previously demonstrated that
matrigel promotes not only cell-matrix interactions but also
cell-cell interactions in MCF7 cells culture (Noel et al., 1988).
The same gel also operated in tumour cell-fibroblasts interac-
tions since in coculture in vitro, MCF7 cells organised into
clusters attached on top offibroblasts aggregates (Noel et al.,
1993). These interactions are modulated by both the soluble
and insoluble forms of laminin and fibronectin. In addition,
when cultured on matrigel, fibroblasts have been shown to
deposit extracellular material, resulting in a progressively
more fibrillar pattern of the matrix gel (Emonard et al.,
1987). Fibroblasts are also known to actively organise the
network of interstitial type I and III fibrils (Bell et al., 1979).
Such rearrangements of the tissue architecture might also
modulate tumour growth.
In conclusion, our results emphasise the importance of
tumour-host interactions and mainly basement membrane
proteins and fibroblasts or their synthetic products on cells
tumorigenicity. Our work also suggests that human tumours
may be reconstituted and grown in athymic nude mice using
stromal and basement membrane components as inducers.
This model may be helpful in the study of factors mediating
cellular interactions during neoplastic progression and for
testing anticancer agents.
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